Delivery Order SPE2DB25D7060-SPE2DB25FXSUR
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,727.12 to AmerisourceBergen Drug Corp for Junel Fe 1.5 mg-30 mcg tablets (28-count packaging) on September 9, 2025, with completion expected by September 10, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $1,966.20 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Junel FE 1 mg-20 mcg tablets in 28-count packaging. This firm fixed price delivery order, with an ultimate completion date of July 22, 2025, represents a non-set-aside competitive award executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Junel Fe 1 mg-20 mcg tablets (a combined oral contraceptive medication) in a 28-tablet package. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $1,478.55 and is scheduled for completion by November 6, 2025. The contract is issued without a set-aside designation, reflecting AmerisourceBergen's competitive capability to serve federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,305.92 to AmerisourceBergen Drug Corp for the supply of Junel FE 1.5 mg-30 mcg tablets (28-count packaging) on November 5, 2025, with an ultimate completion date of November 6, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order valued at $2,623.20 to AmerisourceBergen Drug Corp for the supply of Junel FE 1 mg-20 mcg tablets (28-count packages). This non-set-aside, competitively awarded contract utilizes firm fixed price pricing and has an ultimate completion date of August 25, 2025. The delivery order was issued on August 22, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Junel FE 1.5 mg-30 mcg tablets in quantities of 28 units, with a contract ceiling value of $1,344.48. This competitively awarded, firm fixed-price delivery order is set to be completed by September 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under...
- The Defense Logistics Agency awarded a competitively-awarded delivery order to AmerisourceBergen Drug Corp for $1,036.30 to supply Junel Fe 1.5 mg-30 mcg tablets in a 28-count package. The contract represents a firm fixed-price delivery order issued on November 3, 2025, with an ultimate completion date of November 4, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate office. This delivery order was issued...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,558.38 to AmerisourceBergen Drug Corp for the supply of Junel Fe 1 mg-20 mcg tablets (28-count) on September 8, 2025, with an ultimate completion date of September 9, 2025. This non-set-aside, competitively awarded contract employs firm fixed price pricing and represents a child delivery order issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Junel FE 1 mg-20 mcg tablets (28-count packages) under a firm fixed-price contract with a ceiling value of $2,492.06. This is a competitively awarded, non-set-aside delivery order with an ultimate completion date of September 17, 2025, and performance to be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Junel FE 1.5 mg-30 mcg tablets in a 28-count package. This firm fixed price delivery order, valued at $1,344.48, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion pharmaceutical prime vendor agreement running through December 2026. The contract was competitively awarded with no...
- SPE2DB25D7060Indefinite Delivery Contract
- SPE2DB25D7060-SPE2DB25FXSURDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,493.20 to AmerisourceBergen Drug Corp for the supply of Junel Fe 1 mg-20 mcg tablets in 28-tablet units. This competitive delivery order, which carries no set-aside designation, was awarded on September 22, 2025, with an ultimate completion date of September 23, 2025. The contract employs firm fixed pricing and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical support vehicle that extends through December 2026 and serves as the primary vehicle for delivering pharmaceuticals and medical supplies to military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a substantial federal contracting footprint with the Defense Logistics Agency, supplying brand-name and generic medications, vaccines, and medical devices across multiple therapeutic domains to support the Defense Health Agency and other federal healthcare systems. The company's portfolio demonstrates consistent capability to meet federal procurement requirements through competitive awards ranging from small-value transactions to substantial orders. This particular delivery order for oral contraceptive medication represents a routine transaction within the company's broader mandate to support military medical supply chains across global operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 9/22/25 |